RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,197,830 | -31.1% | 5,136,484 | +2.8% | 0.01% | -28.6% |
| Q2 2023 | $62,736,007 | -11.4% | 4,994,905 | +16.1% | 0.01% | -22.2% |
| Q1 2023 | $70,834,000 | +105970.7% | 4,300,826 | -3.8% | 0.01% | 0.0% |
| Q4 2022 | $66,780 | -99.9% | 4,469,898 | -10.9% | 0.01% | -43.8% |
| Q3 2022 | $112,263,000 | +35.6% | 5,018,487 | +1.5% | 0.02% | +33.3% |
| Q2 2022 | $82,784,000 | -15.5% | 4,942,262 | +50.9% | 0.01% | 0.0% |
| Q1 2022 | $98,003,000 | -5.2% | 3,274,389 | -2.8% | 0.01% | 0.0% |
| Q4 2021 | $103,410,000 | +129.8% | 3,367,312 | +136.0% | 0.01% | +100.0% |
| Q3 2021 | $44,991,000 | -13.6% | 1,426,982 | +0.3% | 0.01% | 0.0% |
| Q2 2021 | $52,080,000 | +9.2% | 1,423,327 | +3.2% | 0.01% | 0.0% |
| Q1 2021 | $47,689,000 | -11.1% | 1,379,506 | +6.9% | 0.01% | -25.0% |
| Q4 2020 | $53,633,000 | +10.5% | 1,290,529 | +6.3% | 0.01% | 0.0% |
| Q3 2020 | $48,554,000 | – | 1,214,438 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |